The efficacy of the treatment has been demonstrated in a randomised, multicentre, comparative clinical study conducted at three pain treatment centres in Switzerland in accordance with EN ISO 14155. (Swissmedic 2018-MD-0002).
The final report stated the following:
In summary, it can be stated that the clinical study demonstrated that treatment with the Elosan Cabin effectively provides additional reduction in chronic pain, even with medication-based therapy administered at maximum dose. For many patients – both in the study and outside of it – significant pain reduction, a reduction in the need to use medication and an improvement in quality of life were documented.
Furthermore, eight consecutive treatment sessions in the Elosan Cabin did not lead to any manifest safety-related concerns. The treatment can be characterised as effective, safe and well-tolerated.
In particular, improved sleep and easing of musculoskeletal tension were observed.
The results of the clinical study were documented and published by Dr Petra Hoederath MD, the study investigator, in December 2019.
The publication appears in the scientific journal Der Schmerz, 1/2020 from Springer Verlag and it can be viewed on PubMed.